Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Codeine	O
/	O
Keflex	O
/	O
Clindamycin	O
/	O
adhesive	O
tape	O
/	O
Gentamicin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
hypoxemia,	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
dCHF,	O
Afib	O
s/p	O
ablation	O
not	O
on	O
Coumadin,	O
dilating	O
ascending	O
aorta,	O
dysphagia	O
s/p	O
G-tube	O
and	O
recent	O
admission	O
___	O
-	O
___	O
for	O
UGIB	B-Upper_gastrointestinal_haemorrhage
with	O
massive	O
transfusion	O
protocol	O
and	O
___	O
embolization,	O
later	O
complicated	O
by	O
PEA	O
arrest	O
and	O
two	O
week	O
intubation	O
with	O
successful	O
extubation	O
and	O
discharge	O
to	O
___	O
that	O
re-presented	O
from	O
rehab	O
yesterday	O
with	O
hypoxia	O
to	O
84%	O
on	O
RA	O
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
.	O
Of	O
note	O
on	O
prior	O
admission	O
admission,	O
EGD	O
revealed	O
a	O
clot	O
near	O
fundus	O
and	O
subsequently	O
underwent	O
___	O
embolization	O
to	O
left	O
gastric	O
artery.	O
Pt	O
was	O
also	O
hypotensive,	O
requiring	O
presoors	O
and	O
had	O
a	O
PEA	O
Arrest	O
requiring	O
intubation	O
during	O
that	O
admission.	O
Pt	O
was	O
treated	O
for	O
HAP	B-Lower_respiratory_tract_infection
with	O
Vancomycin	O
x10d	O
for	O
staph	O
aureus	O
found	O
on	O
sputum	O
cx.	O
Pt	O
dc'd	O
on	O
___	O
to	O
rehab.	O
.	O
While	O
at	O
rehab	O
yesterday	O
pt	O
noted	O
to	O
be	O
hypoxic	O
on	O
RA	O
and	O
improved	O
with	O
4L	O
02.	O
Per	O
report	O
pt	O
was	O
AAOx3	B-Delirium
but	O
unattentive,	O
pt	O
answering	O
only	O
yes	O
or	O
no.	O
Pt	O
was	O
given	O
Zofran	O
for	O
nausea	O
and	O
Lasix	O
20mg	O
IVx1	O
and	O
then	O
transferred	O
to	O
___	O
ED.	O
Labs	O
at	O
rehab	O
since	O
discharge	O
show	O
stable	O
Hct	O
in	O
mid30s,	O
no	O
leukocytosis	O
and	O
chem7	O
that	O
are	O
unremarkable.	O
.	O
Yesterday	O
in	O
the	O
ED,	O
T98.1	O
HR	O
90	O
BP	O
107/56	O
RR	O
20	O
O2	O
sat	O
100%.	O
On	O
exam,	O
guiac	O
neg.	O
Hct	O
stable	O
at	O
34,	O
stable.	O
Pt	O
hypotensive	O
to	O
___,	O
got	O
250cc	O
bolus	O
x1.	O
UA	O
was	O
neg.	O
Labs	O
showed	O
BNP	O
___.	O
CT	O
head	O
was	O
wnl.	O
CTA	O
of	O
chest	O
revealed	O
type	O
B	O
dissection	O
in	O
the	O
mid	O
descending	O
thoracic	O
aorta.	O
Vascular	O
surg	O
evaluated	O
pt	O
and	O
recommended	O
admission	O
to	O
ICU	O
for	O
control	O
of	O
SBP<140.	O
Pt	O
denies	O
pain.	O
Pt	O
then	O
spiked	O
to	O
___.	O
Given	O
a	O
finding	O
of	O
partial	O
LLL	O
collapse,	O
pt	O
was	O
given	O
Vanc/Levo/Cefepime.	O
.	O
Overnight	O
in	O
the	O
unit	O
the	O
pt	O
denied	O
fever,	O
pain,	O
SOB.	O
Pt's	O
children	O
stated	O
since	O
___,	O
pt	O
has	O
not	O
felt	O
with	O
increasing	O
lethargy.	O
like	O
a	O
"zombie".	O
.	O
Currently,	O
upon	O
arrival	O
to	O
the	O
floor.	O
.	O
ROS:	O
Denies	O
fever,	O
chills,	O
night	O
sweats,	O
headache,	O
vision	B-Visual_impairment
changes,	B-Visual_impairment
rhinorrhea,	O
congestion,	O
sore	O
throat,	O
cough,	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation,	B-Constipation
BRBPR,	B-Lower_gastrointestinal_haemorrhage
melena,	B-Upper_gastrointestinal_haemorrhage
hematochezia,	B-Lower_gastrointestinal_haemorrhage
dysuria,	O
hematuria.	O
Past	O
Medical	O
History:	O
#	O
PEA	O
Arrest	O
#	O
Massive	O
UGIB	B-Upper_gastrointestinal_haemorrhage
#	O
Diastolic	O
CHF	O
#	O
Atrial	O
Fibrillation	O
s/p	O
Ablation	O
#	O
Dilated	O
Ascending	O
Aorta	O
#	O
Osteoporosis	O
#	O
Hypothyroidism	O
#	O
Dysphagia	O
for	O
several	O
years	O
with	O
Weight	B-Weight_loss
Loss	B-Weight_loss
s/p	O
G-tube	O
placement	O
#	O
History	O
of	O
PNA	B-Lower_respiratory_tract_infection
requiring	O
VATS	O
pleural	O
effusion	O
drainage	O
and	O
decortication	O
on	O
the	O
right	O
side	O
#	O
Diverticulosis/Diverticulitis	O
#	O
Cerebral	O
Palsy	O
#	O
Macular	B-Visual_impairment
degeneration	B-Visual_impairment
#	O
Ventral	O
Hernias	O
#	O
Rosacia	O
.	O
Past	O
Surgical	O
History:	O
#	O
Status	O
post	O
removal	O
of	O
bowel	O
obstruction	O
due	O
to	O
diverticulitis	O
requiring	O
a	O
temporary	O
colostomy	O
#	O
Status	O
post	O
surgical	O
repair	O
of	O
a	O
prolapsed	O
uterus	O
#	O
Status	O
post	O
total	O
hysterectomy	O
#	O
Status	O
post	O
abdominal	O
surgery	O
secondary	O
to	O
complications	O
of	O
prolapsed	O
uterus	O
surgery	O
-	O
The	O
patient	O
developed	O
multiple	O
hernias.	O
#	O
Status	O
post	O
surgery	O
for	O
exposed	O
keratoses	O
#	O
Status	O
post	O
G-tube	O
placement	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-Contributory	O
Physical	O
Exam:	O
On	O
Transfer	O
to	O
the	O
Medical	O
Floor:	O
VS	O
-	O
97.2	O
71	O
___	O
98%2L	O
I/O	O
+755	O
LOS	O
in	O
ICU	O
GENERAL	O
-	O
Elderly	O
cachectic	B-Malnutrition
ill	O
appearing	O
female	O
in	O
NAD	O
HEENT	O
-	O
EOMI,	O
Dry	O
MM,	O
OP	O
clear	O
NECK	O
-	O
supple,	O
LUNGS	O
-	O
(Anteriorly)	O
Good	O
effort.	O
Dull	O
at	O
right	O
base.	O
Posteriorly,	O
bibasilar	O
course	O
BS.	O
Resp	O
unlabored,	O
without	O
accessory	O
muscle	O
use	O
HEART	O
-	O
___	O
SEM	O
best	O
heard	O
at	O
___.	O
Irregularly	O
irregular.	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND,	O
no	O
rebound/guarding	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e,	O
LYMPH	O
-	O
no	O
cervical,	O
axillary,	O
or	O
inguinal	O
LAD	O
NEURO	O
-	O
awake,	O
A&O	B-Delirium
to	O
person,	O
hospital	O
and	O
year.	O
CNs	O
II-XII	O
grossly	O
intact.	O
On	O
Discharge:	O
VSS,	O
SBP	O
130s-150s	O
GENERAL	O
-	O
Elderly	O
cachectic	O
female	O
in	O
NAD	O
HEENT	O
-	O
EOMI,	O
MMM,	O
OP	O
clear	O
NECK	O
-	O
supple,	O
no	O
___	O
LUNGS	O
-	O
Bibasilar	O
crackles.	O
Resp	O
unlabored,	O
without	O
accessory	O
muscle	O
use	O
HEART	O
-	O
___	O
SEM	O
best	O
heard	O
at	O
___.	O
RRR.	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND,	O
no	O
rebound/guarding	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e,	O
LYMPH	O
-	O
no	O
cervical	O
LAD	O
NEURO	O
-	O
awake,	O
A&O	B-Delirium
x	B-Delirium
3.	B-Delirium
CNs	O
II-XII	O
grossly	O
intact.	O
Pertinent	O
Results:	O
STUDIES:	O
G	O
Tube	O
Check	O
___:	O
IMPRESSION:	O
1.	O
Percutaneous	O
gastric	O
tube	O
remains	O
in	O
place.	O
2.	O
Persistent	O
left	O
basal	O
effusion	O
and	O
atelectasis	O
unchanged.	O
CT	B-Intracranial_haemorrhage
Head	B-Intracranial_haemorrhage
___:	O
IMPRESSION:	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process.	O
CT/CTA	O
___:	O
IMPRESSION:	O
1.	O
Focal	O
area	O
of	O
contrast	O
seen	O
at	O
the	O
aortic	O
lumen	O
in	O
the	O
mid	O
descending	O
thoracic	O
aorta,	O
concerning	O
for	O
a	O
leak	O
with	O
focal	O
type	O
B	O
dissection.	O
A	O
delayed	O
scan	O
could	O
be	O
performed	O
through	O
this	O
area	O
to	O
assess	O
whether	O
it	O
is	O
expanding.	O
2.	O
Area	O
of	O
hypodensity	O
within	O
the	O
descending	O
aorta	O
along	O
the	O
medial	O
and	O
anterior	O
aspect	O
which	O
may	O
represent	O
sequela	O
of	O
prior	O
intramural	O
hematoma.	O
The	O
above	O
findings	O
in	O
items	O
#1	O
and	O
2	O
are	O
new	O
since	O
the	O
CT	O
of	O
___.	O
3.	O
Small	O
penetrating	O
ulcers	O
along	O
aortic	O
arch.	O
4.	O
No	O
pulmonary	O
embolism.	O
5.	O
Ascending	O
aortic	O
aneurysm	O
measuring	O
up	O
to	O
4.3	O
cm,	O
stable	O
since	O
___.	O
6.	O
Partial	O
left	O
lower	O
lobe	O
collapse	O
which	O
appears	O
stable	O
over	O
multiple	O
prior	O
chest	O
x-rays,	O
given	O
differences	O
in	O
modalities.	O
However,	O
this	O
is	O
new	O
since	O
the	O
___	O
CT.	O
7.	O
Aerosolized	O
secretions	O
in	O
the	O
dependent	O
portion	O
of	O
the	O
trachea	O
concerning	O
for	O
aspiration.	O
CXR	O
___:	O
MPRESSION:	O
1.	O
Persistent	O
left	O
base	O
opacity	O
may	O
reflect	O
a	O
combination	O
of	O
small	O
left	O
effusion	O
and	O
left	O
base	O
atelectasis.	O
Slight	O
blunting	O
of	O
the	O
right	O
costophrenic	O
angle	O
may	O
be	O
due	O
to	O
a	O
trace	O
effusion.	O
LABS:	O
___	O
07:10PM	O
BLOOD	O
WBC-8.0	O
RBC-3.74*	O
Hgb-11.2*	O
Hct-33.9*	O
MCV-91	O
MCH-29.8	O
MCHC-32.9	O
RDW-17.7*	O
Plt	O
___	O
___	O
05:16AM	O
BLOOD	O
WBC-8.1	O
RBC-3.12*	O
Hgb-9.6*	O
Hct-28.4*	O
MCV-91	O
MCH-30.9	O
MCHC-33.9	O
RDW-17.9*	O
Plt	O
___	O
___	O
05:23AM	O
BLOOD	O
WBC-5.5	O
RBC-3.14*	O
Hgb-9.7*	O
Hct-28.3*	O
MCV-90	O
MCH-31.0	O
MCHC-34.4	O
RDW-18.0*	O
Plt	O
___	O
___	O
05:46AM	O
BLOOD	O
WBC-5.9	O
RBC-3.35*	O
Hgb-10.6*	O
Hct-30.5*	O
MCV-91	O
MCH-31.8	O
MCHC-34.9	O
RDW-18.4*	O
Plt	O
___	O
___	O
11:40AM	O
BLOOD	O
WBC-6.6	O
RBC-3.59*	O
Hgb-11.4*	O
Hct-33.5*	O
MCV-93	O
MCH-31.6	O
MCHC-34.0	O
RDW-18.3*	O
Plt	O
___	O
___	O
07:10PM	O
BLOOD	O
Glucose-162*	O
UreaN-29*	O
Creat-0.4	O
Na-139	O
K-4.3	O
Cl-98	O
HCO3-34*	O
AnGap-11	O
___	O
03:55AM	O
BLOOD	O
Glucose-163*	O
UreaN-24*	O
Creat-0.3*	O
Na-140	O
K-4.6	O
Cl-100	O
HCO3-36*	O
AnGap-9	O
___	O
05:16AM	O
BLOOD	O
Glucose-148*	O
UreaN-14	O
Creat-0.3*	O
Na-141	O
K-4.0	O
Cl-100	O
HCO3-36*	O
AnGap-9	O
___	O
05:58AM	O
BLOOD	O
Glucose-168*	O
UreaN-11	O
Creat-0.2*	O
Na-138	O
K-3.5	O
Cl-95*	O
HCO3-39*	O
AnGap-8	O
___	O
05:23AM	O
BLOOD	O
Glucose-139*	O
UreaN-10	O
Creat-0.3*	O
Na-141	O
K-3.8	O
Cl-96	O
HCO3-40*	O
AnGap-9	O
___	O
05:46AM	O
BLOOD	O
Glucose-154*	O
UreaN-13	O
Creat-0.3*	O
Na-139	O
K-3.7	O
Cl-93*	O
HCO3-40*	O
AnGap-10	O
___	O
03:55AM	O
BLOOD	O
CK(CPK)-25*	O
___	O
07:10PM	O
BLOOD	O
proBNP-___*	O
___	O
07:10PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
03:55AM	O
BLOOD	O
CK-MB-4	O
cTropnT-0.02*	O
___	O
03:55AM	O
BLOOD	O
Calcium-8.4	O
Phos-3.5	O
Mg-1.9	O
Iron-88	O
___	O
05:46AM	O
BLOOD	O
Calcium-8.9	O
Phos-2.7	O
Mg-1.9	O
___	O
03:55AM	O
BLOOD	O
calTIBC-299	O
Ferritn-182*	O
TRF-230	O
___	O
03:55AM	O
BLOOD	O
TSH-1.4	O
___	O
05:46AM	O
BLOOD	O
Vanco-17.8	O
___	O
04:39PM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-NEG	O
Glucose-100	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-7.5	O
Leuks-NEG	O
MICRO:	O
___	O
7:25	O
pm	O
URINE	O
Site:	O
CLEAN	O
CATCH	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
KLEBSIELLA	O
PNEUMONIAE.	O
10,000-100,000	O
ORGANISMS/ML..	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
KLEBSIELLA	O
PNEUMONIAE	O
|	O
AMPICILLIN/SULBACTAM--	O
4	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
___	O
4:39	O
pm	O
URINE	O
Source:	O
Catheter.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture	O
___:	O
No	O
Growth	O
Brief	O
Hospital	O
Course:	O
___	O
woman	O
with	O
diastolic	O
CHF	O
(LVEF	O
>55%),	O
AF,	O
admitted	O
with	O
hypoxia,	O
and	O
mental	B-Delirium
status	B-Delirium
change	B-Delirium
likely	O
due	O
to	O
LLL	O
HAP	B-Lower_respiratory_tract_infection
and	O
incidentially	O
found	O
to	O
have	O
type	O
B	O
aortic	O
dissection.	O
#	O
HCAP:	B-Lower_respiratory_tract_infection
The	O
patient	O
was	O
found	O
to	O
have	O
a	O
left	O
lower	O
lobe	O
consolidation.	O
Given	O
temperature	O
and	O
hypoxia	O
she	O
was	O
started	O
on	O
cefepime	O
and	O
vancomycin.	O
Her	O
respiratory	O
status	O
improved	O
and	O
her	O
O2	O
was	O
weaned	O
to	O
3L.	O
She	O
became	O
afebrile	O
and	O
her	O
WBC	O
was	O
wnl.	O
She	O
was	O
discharged	O
on	O
Vancomycin	O
750mg	O
IV	O
Q12hrs	O
and	O
Cefipime	O
2grams	O
IV	O
Q24hrs	O
to	O
finish	O
a	O
14	O
day	O
course	O
(started	O
___.	O
She	O
received	O
Albuterol/ipratropium	O
nebulizer	O
treatments	O
Q6h	O
as	O
needed	O
for	O
wheezing.	O
#UTI:	O
the	O
pt	O
was	O
found	O
to	O
have	O
a	O
pan-sensitive	O
Klebsiella	O
UTI	B-Urinary_tract_infection
which	O
required	O
no	O
antibiotics	O
in	O
addition	O
to	O
her	O
anx	O
for	O
HAP.	B-Lower_respiratory_tract_infection
#Urinary	I-Urinary_incontinence
incontinence:	B-Urinary_incontinence
patient	O
with	O
worsening	O
urinary	B-Urinary_incontinence
incontinence	B-Urinary_incontinence
over	O
course	O
of	O
hospitalization.	O
Urine	B-Urinary_tract_infection
cx	O
w/	O
___	O
Klebsiella	O
covered	O
by	O
IV	O
abx	O
(cefepime).	O
Repeat	O
UA	O
with	O
no	O
evidence	O
of	O
infection.	B-Urinary_tract_infection
Incontinence	B-Urinary_incontinence
may	O
be	O
secondary	O
to	O
frequent	O
catheterization	O
over	O
past	O
several	O
weeks.	O
#	O
Type	O
B	O
aortic	O
dissection:	O
The	O
patient	O
had	O
a	O
CTA	O
chest	O
to	O
evaluate	O
for	O
pulmonary	O
embolus	O
as	O
cause	O
of	O
hypoxia.	O
She	O
was	O
found	O
to	O
have	O
a	O
type	O
B	O
aortic	O
dissection.	O
Vascular	O
surgery	O
was	O
consulted	O
and	O
recommended	O
medical	O
management	O
which	O
the	O
family	O
is	O
in	O
agreement	O
with.	O
The	O
patient's	O
antihypertensive	O
regimen	O
was	O
adjusted	O
to	O
maintain	O
systolic	O
blood	O
pressures	O
under	O
140.	O
BPs	O
at	O
the	O
time	O
of	O
discharge	O
130-150s.	O
Discharge	O
regimen:	O
Metoprol	O
12.5mg	O
BID,	O
Lisinopril	O
40mg	O
Daily,	O
Norvasc	O
5mg	O
Daily.	O
Also	O
thought	O
to	O
be	O
anxiety	O
component	O
to	O
hypertension.	O
Patient	O
responded	O
well	O
to	O
0.125mg	O
Ativan	O
PO	O
BID	O
prn.	O
#	O
Altered	B-Delirium
Mental	B-Delirium
Status:	B-Delirium
CT	O
head	O
without	O
acute	O
process.	O
Likely	O
related	O
to	O
hypoxia	O
and	O
infection	O
as	O
improved	O
with	O
treatment.	O
Patient	O
at	O
baseline	O
at	O
the	O
time	O
of	O
discharge	O
per	O
family	O
members.	O
Patient	O
should	O
be	O
reoriented	O
frequently	O
and	O
be	O
out	O
of	O
bed	O
to	O
chair	O
as	O
much	O
as	O
possible	O
during	O
the	O
day.	O
Non-pharmacologic	O
measures	O
including	O
lights	O
on/blinds	O
up	O
during	O
the	O
day	O
and	O
lights	O
off/blinds	O
down	O
at	O
night.	O
#	O
A	O
Fib	O
	O
Rate	O
controlled.	O
Patient	O
restarted	O
on	O
Aspirin	O
with	O
the	O
approval	O
of	O
the	O
vascular	O
surgery	O
team.	O
#	O
Anemia	O
	O
The	O
patient's	O
hematocrit	O
remained	O
stable	O
at	O
approximately	O
30.	O
Iron	O
studies	O
were	O
sent.	O
Ferritin	O
slightly	O
elevated.	O
Other	O
studies	O
wnl.	O
No	O
signs	O
of	O
active	O
bleeding.	O
#	O
Chronic	O
Diastolic	O
CHF:	O
No	O
evidence	O
of	O
fluid	O
overload.	O
#Rising	O
Bicarb	O
-	O
Likely	O
contraction	O
alkalosis	O
noted	O
which	O
may	O
be	O
secondary	O
to	O
concentrated	O
tube	O
feeds.	O
Discusse	O
with	O
nutrition	O
who	O
recommended	O
increasing	O
free	O
water	O
flushes	O
to	O
300cc	O
before	O
and	O
after	O
meals.	O
Patient	O
did	O
not	O
tolerate	O
volume	O
so	O
changed	O
to	O
300cc	O
flushes	O
every	O
4	O
hrs	O
which	O
was	O
well	O
tolerated.	O
#Photophobia	I-Visual_impairment
and	O
eye	O
discomfort:	O
All	O
eye	O
drops	O
and	O
ointments	O
were	O
continued.	O
Opthalmology	O
consulted	O
and	O
recommended	O
contuing	O
her	O
eye	O
care	O
regimen,	O
with	O
the	O
addition	O
of	O
increasing	O
the	O
frequency	O
of	O
artificial	O
tears	O
application	O
as	O
well	O
as	O
periodic	O
gentle	O
mechanical	O
debridement	O
of	O
mucous	O
film	O
and	O
mechanical	O
opening	O
and	O
closing	O
of	O
lids	O
to	O
imrove	O
vision.	O
Patient	O
may	O
wear	O
dark	O
sunglasses	O
as	O
per	O
comfort.	O
#Dysphagia:	O
G	O
tube	O
in	O
place.	O
Tube	O
feeds	O
continued.	O
Patient	O
NPO	O
due	O
to	O
risk	O
for	O
aspiration.	O
Continue	O
Omeprazole	O
20mg	O
PO	O
BID.	O
#	O
Hypothyroidism:	O
Stable,	O
Continued	O
home	O
levothyroxine	O
#	O
Osteoperosis:	O
Stable.	O
Continued	O
Vit	O
D	O
and	O
Calcium.	O
Due	O
for	O
Boniva	O
infusion	O
but	O
not	O
possible	O
in	O
house.	O
#	O
PPX:	O
Heparin	O
SQ	O
TID,	O
bowel	O
regimen	O
#	O
ACCESS:	O
___	O
(R)	O
-	O
no	O
signs	O
or	O
symptoms	O
of	O
line	O
infection.	O
#	O
CODE	O
STATUS:	O
Full	O
Code	O
confirmed	O
Medications	O
on	O
Admission:	O
1.	O
erythromycin	O
5	O
mg/gram	O
(0.5	O
%)	O
Ointment	O
one	O
drop	O
in	O
each	O
eye	O
2.	O
bacitracin-polymyxin	O
B	O
500-10,000	O
unit/g	O
Ointment	O
apply	O
to	O
both	O
eyes	O
3.	O
Diazepam	O
0.5	O
mg	O
at	O
bedtime	O
4.	O
Levothyroxine	O
50	O
mcg	O
DAILY	O
5.	O
Omeprazole	O
20mg	O
BID	O
6.	O
Guaifenesin	O
100	O
mg/5	O
mL	O
Syrup	O
every	O
6	O
hours	O
7.	O
quetiapine	O
12.5	O
mg	O
QHS	O
as	O
needed	O
for	O
agitation,	O
insomnia	O
8.	O
Acetaminophen	O
325	O
mg	O
every	O
6	O
hours	O
as	O
needed	O
for	O
pain,	O
headache,	O
fever	O
9.	O
cholecalciferol	O
(vitamin	O
D3)	O
1000	O
unit	O
DAILY	O
10.	O
ferrous	O
sulfate	O
300	O
mg	O
(60	O
mg	O
Iron)/5	O
mL	O
DAILY	O
11.	O
moxifloxacin	O
0.5	O
%	O
Drops	O
both	O
eyes	O
TID	O
as	O
needed	O
for	O
eye	O
redness/irritation	O
12.	O
atropine	O
1	O
%	O
Drops	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
oral	O
secretions	O
13.	O
therapeutic	O
multivitamin	O
Liquid	O
DAILY	O
14.	O
zinc	O
sulfate	O
220	O
mg	O
DAILY	O
15.	O
ascorbic	O
acid	O
___	O
mg/5	O
mL	O
DAILY	O
16.	O
albuterol	O
sulfate	O
0.63	O
mg/3	O
mL	O
every	O
six	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing	O
17.	O
ipratropium	O
bromide	O
0.02	O
%	O
every	O
six	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing	O
18.	O
artificial	O
Tears	O
every	O
four	O
hours	O
as	O
needed	O
for	O
dry	O
eyes	O
19.	O
lisinopril	O
10mg	O
daily	O
(started	O
on	O
___	O
20.	O
calcium	O
carbonate	O
650mg	O
BID	O
21.	O
senna	O
BID	O
22.	O
maalox	O
30ml	O
q6h	O
23.	O
Boniva	O
q3months	O
(next	O
dose	O
due	O
___	O
.	O
MEDICATIONS	O
ON	O
TRANSFER:	O
Acetaminophen	O
325-650	O
mg	O
PO/NG	O
Q6H:PRN	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H:PRN	O
Artificial	O
Tears	O
___	O
DROP	O
BOTH	O
EYES	O
PRN	O
Bacitracin/Polymyxin	O
B	O
Sulfate	O
Calcium	O
Carbonate	O
500	O
mg	O
PO/NG	O
BID	O
CefePIME	O
2	O
g	O
IV	O
Q24H	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
Erythromycin	O
0.5%	O
Ophth	O
Oint	O
0.5	O
in	O
BOTH	O
Ferrous	O
Sulfate	O
(Liquid)	O
300	O
mg	O
PO/NG	O
DAILY	O
Fluconazole	O
100	O
mg	O
PO/NG	O
Q24H	O
Heparin	O
5000	O
UNIT	O
SC	O
BID	O
Ipratropium	O
Bromide	O
Neb	O
1	O
NEB	O
IH	O
Q6H:PRN	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO/NG	O
DAILY	O
Omeprazole	O
20	O
mg	O
PO	O
BID	O
Senna	O
1	O
TAB	O
PO/NG	O
BID:PRN	O
Discharge	O
Medications:	O
1.	O
albuterol	O
sulfate	O
2.5	O
mg	O
/3	O
mL	O
(0.083	O
%)	O
Solution	O
for	O
Nebulization	O
Sig:	O
One	O
(1)	O
Inhalation	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
SOB/wheezing.	O
2.	O
ipratropium	O
bromide	O
0.02	O
%	O
Solution	O
Sig:	O
One	O
(1)	O
Inhalation	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
SOB/wheezing.	O
3.	O
omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
4.	O
levothyroxine	O
50	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
pain,	O
fever.	O
6.	O
ferrous	O
sulfate	O
300	O
mg	O
(60	O
mg	O
Iron)/5	O
mL	O
Liquid	O
Sig:	O
One	O
(1)	O
PO	O
DAILY	O
(Daily).	O
7.	O
calcium	O
carbonate	O
200	O
mg	O
(500	O
mg)	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
8.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
9.	O
heparin	O
(porcine)	O
5,000	O
unit/mL	O
Solution	O
Sig:	O
One	O
(1)	O
Injection	O
TID	O
(3	O
times	O
a	O
day).	O
10.	O
cholecalciferol	O
(vitamin	O
D3)	O
400	O
unit	O
Tablet	O
Sig:	O
2.5	O
Tablets	O
PO	O
DAILY	O
(Daily).	O
11.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
12.	O
lisinopril	O
20	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
13.	O
metoprolol	O
tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
14.	O
bisacodyl	O
10	O
mg	O
Suppository	O
Sig:	O
One	O
(1)	O
Suppository	O
Rectal	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
constipation.	B-Constipation
15.	O
erythromycin	O
5	O
mg/gram	O
(0.5	O
%)	O
Ointment	O
Sig:	O
One	O
(1)	O
application	O
Ophthalmic	O
QHS	O
(once	O
a	O
day	O
(at	O
bedtime)):	O
use	O
one	O
ointment	O
or	O
the	O
other	O
-	O
not	O
both.	O
16.	O
bacitracin-polymyxin	O
B	O
500-10,000	O
unit/g	O
Ointment	O
Sig:	O
One	O
(1)	O
Appl	O
Ophthalmic	O
QHS	O
(once	O
a	O
day	O
(at	O
bedtime)):	O
use	O
one	O
ointment	O
or	O
the	O
other	O
-	O
not	O
both.	O
17.	O
moxifloxacin	O
0.5	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
drops	O
Ophthalmic	O
TID	O
prn	O
()	O
as	O
needed	O
for	O
eye	O
irritation.	O
18.	O
gatifloxacin	O
0.3	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
drop	O
Ophthalmic	O
4	O
x	O
a	O
day,	O
___	O
().	O
19.	O
polyvinyl	O
alcohol	O
1.4	O
%	O
Drops	O
Sig:	O
___	O
Drops	O
Ophthalmic	O
Q2H	O
(every	O
2	O
hours).	O
20.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
21.	O
lorazepam	O
0.5	O
mg	O
Tablet	O
Sig:	O
___	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
anxiety.	O
Tablet(s)	O
22.	O
amlodipine	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
23.	O
vancomycin	O
500	O
mg	O
Recon	O
Soln	O
Sig:	O
1.5	O
Recon	O
Solns	O
Intravenous	O
Q	O
12H	O
(Every	O
12	O
Hours).	O
24.	O
cefepime	O
2	O
gram	O
Recon	O
Soln	O
Sig:	O
One	O
(1)	O
Recon	O
Soln	O
Injection	O
Q24H	O
(every	O
24	O
hours).	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Hospital	B-Lower_respiratory_tract_infection
Acquired	B-Lower_respiratory_tract_infection
Pneumonia	B-Lower_respiratory_tract_infection
UTI	B-Urinary_tract_infection
Dilated	O
Ascending	O
Aorta	O
w/	O
Type	O
B	O
Aortic	O
Dissection	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	O
chair	O
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
after	O
you	O
were	O
found	O
to	O
have	O
a	O
low	O
oxygen	O
level	O
and	O
a	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status.	B-Delirium
You	O
were	O
initially	O
admitted	O
to	O
the	O
ICU	O
and	O
after	O
one	O
night	O
were	O
transfered	O
to	O
a	O
medicine	O
floor.	O
You	O
were	O
found	O
to	O
have	O
a	O
pneumonia	B-Lower_respiratory_tract_infection
and	O
you	O
received	O
intravenous	O
antiobiotics.	O
You	O
were	O
also	O
found	O
to	O
have	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
during	O
your	O
stay	O
which	O
was	O
also	O
treated	O
by	O
the	O
antibiotics	O
that	O
you	O
were	O
on	O
for	O
the	O
penumonia.	B-Lower_respiratory_tract_infection
Your	O
infections	O
are	O
the	O
most	O
likely	O
cause	O
of	O
your	O
low	O
oxygen	O
levels	O
and	O
your	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status.	B-Delirium
You	O
required	O
supplemental	O
oxygen	O
in	O
order	O
to	O
keep	O
your	O
oxygen	O
levels	O
up	O
and	O
you	O
will	O
return	O
to	O
your	O
rehabilitation	O
center	O
on	O
oxygen.	O
We	O
also	O
adjusted	O
your	O
medications	O
to	O
control	O
your	O
blood	O
pressure	O
with	O
a	O
goal	O
systolic	O
blood	O
pressure	O
of	O
140	O
or	O
less	O
and	O
treated	O
you	O
for	O
anxiety.	O
You	O
were	O
seen	O
by	O
ophthamology	O
during	O
your	O
stay	O
who	O
recommended	O
that	O
you	O
continue	O
your	O
regimen	O
of	O
eye	O
drops	O
and	O
ointments	O
and	O
also	O
remove	O
the	O
mucous	O
from	O
your	O
eyes	O
and	O
open	O
and	O
close	O
the	O
lids	O
manually	O
as	O
needed	O
to	O
improve	O
your	O
vision.	O
Followup	O
Instructions:	O
___	O

